Nov
DEC
Jan
19
2014
2015
2016
1 captures
19 Dec 15 - 19 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Diabetes Mellitus
Left Ventricular Remodeling Reduced with Olmesartan in ROADMAP
Psychosocial Issues in Diabetes
LEADER Study: Testing the Cardiovascular Safety of Liraglutide
Improved Treatment of Type 2 Diabetes: Results from the 4B Trial
Cardiovascular Safety of Linagliptin Demonstrated in Pooled Analysis
Once-Weekly Exenatide Allows Sustained HbA1C Control
ENDURE: Alogliptin Effective and Safe through 2 Years
Liraglutide is a Safe and Beneficial Adjunct to Insulin in Glycemic Control in Type 1 Diabetes
Trough DPP-4 Inhibition Differs between the Approved DPP-4 Inhibitors
Fixed-Ratio Combination of Insulin Degludec and Liraglutide Improves Glycemic Control in Type 2 Diabetes
Pages
Previous
Next
1
…
4
5
6
7
8
9
10
11
12
…
30